Petros Grivas, Professor at University of Washington and Fred Hutch, shared on X:
“Proud of our amazing leader, Fred Hutch Cancer Center, UW Medicine HemOnc Division Chief, Dr. Sara Hurvitz, who led/presented ASCO26 VIKTORIA-1 trial data that led to FDA approval of gedatolisib in metastatic breast cancer great news for patients!”
Other posts featuring Sara Hurvitz on OncoDaily.